Cardiovascular sequelae of dengue fever: a systematic review

Expert Rev Cardiovasc Ther. 2022 Jun;20(6):465-479. doi: 10.1080/14779072.2022.2082945. Epub 2022 Jun 2.

Abstract

Introduction: Dengue is one of the most important viral diseases globally and a majority of symptomatic infections result in a benign course. However, a small number of patients develop severe manifestations, including the cardiovascular (CV) manifestations, including myocardial impairment, arrhythmias, and fulminant myocarditis.

Areas covered: Electronic databases, including PubMed/MEDLINE, EMBASE, Scopus, and CINAHL were searched for articles incorporating CV manifestations of dengue fever (DF).

Expert opinion: Included studies involved 6,773 patients, and 3,122 (46.1%) exhibited at least one cardiac manifestation. Electrocardiogram (ECG) abnormalities (30.6%) included sinus bradycardia (8.8%), nonspecific ST-T changes (8.6%), ST depression (7.9%), and T-wave inversion (2.3%). Mechanical sequelae were present in 10.4%, including left ventricular (LV) systolic dysfunction (5.7%), and myocarditis (2.9%). Pericardial involvement was noted as pericarditis (0.1%), pericardial effusion (1.3%), and pericardial tamponade (0.1%). Apart from that, the cardiac injury was depicted through a rise in cardiac enzymes (4.5%). The spectrum of CV manifestations in dengue is broad, ranging from subtle ST-T changes to fulminant myocarditis and the use of contemporary techniques in diagnosing cardiac involvement should be employed for rapid diagnosis and treatment.

Keywords: Aedes aegypti; dengue hemorrhagic fever; dengue shock syndrome; myocarditis; pseudoaneurysm.

Publication types

  • Systematic Review

MeSH terms

  • Arrhythmias, Cardiac
  • Cardiac Tamponade* / complications
  • Cardiac Tamponade* / diagnosis
  • Dengue* / complications
  • Dengue* / diagnosis
  • Disease Progression
  • Humans
  • Myocarditis* / diagnosis
  • Pericardial Effusion*
  • Pericarditis* / diagnosis